| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/04/1996 | WO1996010038A1 Multifunctional molecular complexes for gene transfer to cells |
| 04/04/1996 | WO1996010030A1 Oligomers having heteroatom-linked conjugate groups |
| 04/04/1996 | WO1996009816A1 Medicaments |
| 04/04/1996 | WO1996009815A1 Starch products as tabletting excipient, method for preparing same, and method for making tablets |
| 04/04/1996 | WO1996009813A1 Diketopiperazine-based delivery systems |
| 04/04/1996 | WO1996009811A1 Improved carriers for antibiotic agents |
| 04/04/1996 | WO1996009805A2 Chitosan induced immunopotentiation |
| 04/04/1996 | WO1996008274A3 Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents |
| 04/04/1996 | DE4435087A1 Konjugat zur Behandlung von Infektions-, Autoimmun- und Hauterkrankungen Conjugate for treatment of infectious and autoimmune diseases |
| 04/04/1996 | DE4434986A1 Verfahren zur Herstellung wäßriger Lösungen von Poly(N-vinyl-epsilon-caprolactam) und ihre Verwendung A process for the preparation of aqueous solutions of poly (N-vinyl-epsilon-caprolactam), and their use |
| 04/04/1996 | CA2200550A1 Chitosan induced immunopotentiation |
| 04/03/1996 | EP0704222A1 In vivo degradable medical device, composition and method for its production and process for its decomposition |
| 04/03/1996 | EP0704221A2 A conjugate useful in gene transfer and a method of producing the same |
| 04/03/1996 | EP0704212A2 Method of minimizing hepatic reperfusion injury |
| 04/03/1996 | EP0704209A1 Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid |
| 04/03/1996 | EP0704208A2 Coating and binder compositions for pharmaceutical forms and pharmaceutical forms prepared therewith |
| 04/03/1996 | EP0704207A2 Thermoplastic resin for enteric pharmaceutical coating |
| 04/03/1996 | EP0703926A1 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 04/03/1996 | EP0703779A1 Compressible enzyme powder |
| 04/03/1996 | EP0535091B1 Osteoinductive pharmaceutical formulations |
| 04/03/1996 | EP0532611B1 Process for the manufacture of porous cellulose matrices |
| 04/03/1996 | EP0526561B1 Composition for transdermal penetration of medicaments |
| 04/03/1996 | EP0478715B1 Targeted liposomes and methods for liposome-protein coupling |
| 04/03/1996 | EP0328589B1 Tetra-aza macrocycles and metal complexes thereof |
| 04/03/1996 | CN1119829A Vaccine compositions containing 3-O deacylated monophosphoryl lipid a |
| 04/03/1996 | CN1119828A Cross-linked amylose as a binder/disintegrant in tablets |
| 04/03/1996 | CN1119531A A stably storable and readily water soluble composition of cephalosporin for injections |
| 04/02/1996 | USRE35200 Coating for pharmaceutical dosage forms |
| 04/02/1996 | US5504216 Method for reparing an amorphous sulfonamide |
| 04/02/1996 | US5504113 Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug |
| 04/02/1996 | US5504105 In oily vehicles that promote absorption enabling dosage to be simplified |
| 04/02/1996 | US5504102 Solution of teniposide, paclitaxel, or camptothecin and derivatives antitumor agent and polyethoxylated castor oil mixed with acid to lower the carboxylate anion content; shelf-life, by-product inhibition |
| 04/02/1996 | US5504099 Storage stable aqueous diuretic solution containing azosemide salt of organic amine and biocompatible organic solvent |
| 04/02/1996 | US5504068 Topical preparations containing cyclosporin |
| 04/02/1996 | US5503862 Reducing temperature by mixing in fructose, maltodextrin and/or polydextrose |
| 04/02/1996 | US5503852 Cyclodimerization of amino acids, precipitation of microparticles; for encapsulating drugs |
| 04/02/1996 | US5503848 Topical dose of sterile, slow-release, lyophilized non-crosslinked hyaluronic acid ester; wound healing agents, ears |
| 04/02/1996 | US5503847 Hydrocolloid wound gel |
| 04/02/1996 | US5503843 Transdermal delivery of alpha adrenoceptor blocking agents |
| 04/02/1996 | US5503842 Polymer surfaced articles coated with medicants and flavorants for medical and dental use |
| 04/02/1996 | US5503838 Iodine barrier teat dip |
| 04/02/1996 | US5503833 VP6 encapsulated drug delivery |
| 04/02/1996 | US5503827 Process for the production of multi-dose pharmaceutical preparations containing isolated or recombinantly produced human protein for infusion or injection purposes |
| 04/02/1996 | US5503746 Thin, self-interlocking, tactic polyvinyl alcohol, retaining geometric configuration |
| 03/29/1996 | CA2159288A1 Aqueous nasal suspension |
| 03/28/1996 | WO1996009398A1 Gene constructs encoding crop-protecting agents, as well as transformed plants containing and expressing such constructs, and methods of controlling plague organisms and pathogens in crops |
| 03/28/1996 | WO1996009326A1 Reversible and controllable closing and opening of the guest-binding cavity of cyclodextrin derivatives and related host molecules |
| 03/28/1996 | WO1996009315A1 Dna photocleavage using texaphyrins |
| 03/28/1996 | WO1996009078A1 Formulations for delivery of osteogenic proteins |
| 03/28/1996 | WO1996009073A1 Biodegradable medicinal polymer assembly with supermolecular structure |
| 03/28/1996 | WO1996009072A1 Estramustine formulations with improved pharmaceutical properties |
| 03/28/1996 | WO1996009071A1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 03/28/1996 | WO1996009070A1 Use of starch for transdermal applications |
| 03/28/1996 | WO1996009068A1 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 03/28/1996 | WO1996007738A3 Modified human c3 proteins |
| 03/28/1996 | DE4433890A1 Konjugat aus einem Wirkstoff und einem nicht als körperfremd angesehenen, nativen Protein Conjugate of an active agent and a non-prestigious as foreign, native protein |
| 03/28/1996 | CA2200571A1 Dna photocleavage using texaphryns |
| 03/28/1996 | CA2200434A1 Gene constructs encoding crop-protecting agents, as well as transformed plants containing and expressing such constructs, and methods of controlling plague organisms and pathogensin crops |
| 03/28/1996 | CA2176383A1 Supramolecular-structure biodegradable polymeric assembly for drug delivery |
| 03/28/1996 | CA2174968A1 Estramustine formulations with improved pharmaceutical properties |
| 03/27/1996 | EP0703217A1 Fluorinated alkylesters containing a urethane group, their preparation their use as thickeners in non-aqueous media and media and compositions containing them |
| 03/27/1996 | EP0702958A1 Vaginal preparation containing physiologically active peptide |
| 03/27/1996 | EP0702957A1 Extracts of St.John's wort |
| 03/27/1996 | EP0702793A1 Anti-cd3 antibody-aminodextran conjugates for induction of t-cell activation and proliferation |
| 03/27/1996 | EP0702723A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 03/27/1996 | EP0702722A1 Plasmids suitable for gene therapy |
| 03/27/1996 | EP0702685A1 Texaphyrin metal complex mediated ester hydrolysis |
| 03/27/1996 | EP0702568A1 An emollient composition |
| 03/27/1996 | EP0702567A1 Methods and compositions for aiding periodontal tissue regeneration |
| 03/27/1996 | EP0702562A1 Cyclosporin-containing powder composition |
| 03/27/1996 | EP0702557A1 Therapeutic inhibitor of vascular smooth muscle cells |
| 03/27/1996 | EP0702552A1 Solid fat nanoemulsions as drug delivery vehicles |
| 03/27/1996 | EP0662836A4 Germicidal detergent-iodine compositions having reduced detergent content. |
| 03/27/1996 | EP0593506B1 Lipoaminoacids, preparation method and applications |
| 03/27/1996 | EP0549617B1 Improved vaccine compositions |
| 03/27/1996 | EP0498841B1 Bioadhesive composition and patch |
| 03/27/1996 | EP0495053B1 New linker for bioactive agents |
| 03/27/1996 | EP0473687B1 Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester |
| 03/27/1996 | CN1119459A Process for preparing cancer vaccines |
| 03/27/1996 | CN1119414A Stabilised pharmaceutical compositions and methods for preparing same |
| 03/27/1996 | CA2159034A1 Method of minimizing hepatic reperfusion injury |
| 03/26/1996 | US5502180 Inulin derivatives, process for their preparation and their use |
| 03/26/1996 | US5502081 Compositions for surgical aids formed from reaction of carbodiimide with hyaluronic acid |
| 03/26/1996 | US5502075 Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents |
| 03/26/1996 | US5502056 Stimulant, antisoporific, salt with p-aminobenzoic acid |
| 03/26/1996 | US5502037 Antitumor agents for procytotoxic drugs |
| 03/26/1996 | US5501863 Contrast media synthesized from polyaldehydes |
| 03/26/1996 | US5501861 Carbohydrates |
| 03/26/1996 | US5501858 Rapidly dispersable compositions containing polydextrose |
| 03/26/1996 | US5501856 Controlled-release pharmaceutical preparation for intra-ocular implant |
| 03/26/1996 | US5501849 Emollient composition |
| 03/26/1996 | CA2062582C Methods and substances for recruiting therapeutic agents to solid tissues |
| 03/26/1996 | CA2041044C Large intestinal dissociative polypeptide series oral formulation |
| 03/22/1996 | CA2158723A1 Fluorinated compounds; processes for preparing and using them; media and compositions containing said compounds |
| 03/21/1996 | WO1996008560A1 Transduction of genes into human hematopoietic stem cells using recombinant adeno-associated viral vectors |
| 03/21/1996 | WO1996008517A1 Water-soluble dextran fatty acid esters and their use as solubilisers |
| 03/21/1996 | WO1996008513A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same |
| 03/21/1996 | WO1996008274A2 Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents |
| 03/21/1996 | WO1996008273A1 Pharmaceutical compositions containing d2o |
| 03/21/1996 | WO1996008263A1 Intracellular delivery of chemical agents to a specific cell type |